| 1 | Carcinosarcoma | 27.6% |
| 2 | Composite Lymphoma | 25.8% |
| 3 | Mesenchymoma | 25.6% |
| 4 | Hepatoblastoma | 25.6% |
| 5 | Mixed Tumor, Mullerian | 25.6% |
| 6 | Carcinoma 256, Walker | 23.7% |
| 7 | Histiocytic Disorders, Malignant | 23.5% |
| 8 | Splenic Neoplasms | 22.1% |
| 9 | Neoplasms, Neuroepithelial | 20.2% |
| 10 | Gliomatosis cerebri | 20.2% |
| 11 | Neuroectodermal Tumors | 19.9% |
| 12 | Lymphocele | 19.7% |
| 13 | Lymphoma | 19.6% |
| 14 | leukemia | 19.3% |
| 15 | Neoplasms, Germ Cell and Embryonal | 19.3% |
| 16 | Neoplasms, Glandular and Epithelial | 19.3% |
| 17 | Germ Cell Cancer | 19.3% |
| 18 | Endometrial Stromal Sarcoma | 18.5% |
| 19 | Hematologic Neoplasms | 18.4% |
| 20 | melanoma | 17.9% |
| 21 | Medulloblastoma | 17.8% |
| 22 | Abdominal Neoplasms | 17.6% |
| 23 | Head and Neck Neoplasms | 17.6% |
| 24 | Soft Tissue Neoplasms | 17.6% |
| 25 | Meningioma | 17.3% |
| 26 | Hemangiosarcoma | 17.1% |
| 27 | lymphangiosarcoma | 17.1% |
| 28 | Hamartoma | 16.5% |
| 29 | Neoplasms, Hormone-Dependent | 16.5% |
| 30 | Neoplasms, Multiple Primary | 16.5% |
| 31 | Paraneoplastic Syndromes | 16.5% |
| 32 | Precancerous Conditions | 16.5% |
| 33 | Neoplasms, Second Primary | 16.5% |
| 34 | Malignant histiocytosis | 15.8% |
| 35 | Histiocytic sarcoma | 15.8% |
| 36 | Acanthoma | 15.8% |
| 37 | Adenoma, Acidophil | 15.7% |
| 38 | Ganglioneuroma | 15.7% |
| 39 | Glioma | 15.7% |
| 40 | Malignant Glioma | 15.7% |
| 41 | Melanoma, Experimental | 15.5% |
| 42 | Carcinoma, Lobular | 15.4% |
| 43 | Adenitis | 15.1% |
| 44 | Histiocytosis | 15.1% |
| 45 | Lymphadenitis | 15.1% |
| 46 | Lymphangitis | 15.1% |
| 47 | Lymphedema | 15.1% |
| 48 | Splenic Diseases | 15.1% |
| 49 | Thymus Hyperplasia | 15.1% |
| 50 | Pseudolymphoma | 15.1% |
| 51 | Lymphadenopathy | 15.1% |
| 52 | Multiple Endocrine Neoplasia | 14.9% |
| 53 | Digestive System Neoplasms | 14.7% |
| 54 | Endocrine Gland Neoplasms | 14.7% |
| 55 | Eye Neoplasms | 14.7% |
| 56 | Nervous System Neoplasms | 14.7% |
| 57 | Carcinoma, Ehrlich Tumor | 14.7% |
| 58 | Dermoid Cyst | 14.7% |
| 59 | Carcinoma, Lewis Lung | 14.7% |
| 60 | Nephroblastoma | 14.6% |
| 61 | Carcinoid Tumor | 14.6% |
| 62 | Neurilemmoma | 14.6% |
| 63 | Hutchinson's Melanotic Freckle | 14.6% |
| 64 | Melanoma, Amelanotic | 14.6% |
| 65 | Trophoblastic Neoplasms | 14.5% |
| 66 | Leukemia, Experimental | 14.4% |
| 67 | Tracheal Neoplasms | 14.4% |
| 68 | Lymphangioleiomyomatosis | 14.4% |
| 69 | Basal cell carcinoma | 14.4% |
| 70 | Carcinoma, Papillary | 14.4% |
| 71 | Squamous cell carcinoma | 14.4% |
| 72 | Chondrosarcoma | 14.4% |
| 73 | Craniopharyngioma | 14.4% |
| 74 | Cystadenoma | 14.4% |
| 75 | leiomyosarcoma | 14.4% |
| 76 | liposarcoma | 14.4% |
| 77 | Mesothelioma | 14.4% |
| 78 | synovial sarcoma | 14.4% |
| 79 | Neuroectodermal Tumor, Melanotic | 14.4% |
| 80 | Angiomyolipoma | 14.4% |
| 81 | Clear Cell Sarcoma of Soft Tissue | 14.4% |
| 82 | Alveolar Soft Part Sarcoma | 14.4% |
| 83 | Neuroendocrine Tumors | 14.4% |
| 84 | Sarcoma, Myeloid | 14.4% |
| 85 | Carcinoma, Basal Cell | 14.4% |
| 86 | Bone neoplasms | 14.3% |
| 87 | Skin Neoplasms | 14.3% |
| 88 | Leukemia, Plasma Cell | 14.2% |
| 89 | Mesoblastic Nephroma | 13.7% |
| 90 | Paraneoplastic Encephalomyelitis | 13.6% |
| 91 | Astrocytoma | 13.4% |
| 92 | Ependymoma | 13.4% |
| 93 | oligodendroglioma | 13.4% |
| 94 | Ganglioglioma | 13.4% |
| 95 | gliosarcoma | 13.4% |
| 96 | Anaplastic astrocytoma | 13.4% |
| 97 | Anaplastic Oligodendroglioma | 13.4% |
| 98 | Mammary Neoplasms, Experimental | 13.3% |
| 99 | Cyst | 13.3% |
| 100 | Neoplastic Processes | 13.3% |
| 101 | Neoplastic Syndromes, Hereditary | 13.3% |
| 102 | Pregnancy Complications, Neoplastic | 13.3% |
| 103 | Lymphangiectasis, Intestinal | 13.3% |
| 104 | Hodgkin Disease | 13.1% |
| 105 | Lymphoma, Non-Hodgkin | 13.1% |
| 106 | Neoplasms, Experimental | 13.1% |
| 107 | Cystadenocarcinoma | 13% |
| 108 | Fibrosarcoma | 13% |
| 109 | Osteosarcoma | 13% |
| 110 | Mucoepidermoid Carcinoma | 13% |
| 111 | Malignant Carcinoid Syndrome | 12.9% |
| 112 | Choriocarcinoma | 12.6% |
| 113 | Parathyroid Neoplasms | 12.6% |
| 114 | Peritoneal Neoplasms | 12.6% |
| 115 | Thyroid Neoplasm | 12.6% |
| 116 | Thyroid carcinoma | 12.6% |
| 117 | Leukemia, Radiation-Induced | 12.5% |
| 118 | Lymphomatoid Granulomatosis | 12.5% |
| 119 | Retinoblastoma | 12.5% |
| 120 | Adenoma | 12.4% |
| 121 | Ameloblastoma | 12.4% |
| 122 | Angiokeratoma | 12.4% |
| 123 | Carcinoma | 12.4% |
| 124 | Chordoma | 12.4% |
| 125 | Hemangioma | 12.4% |
| 126 | hemangiopericytoma | 12.4% |
| 127 | Lymphangioma | 12.4% |
| 128 | Nevus | 12.4% |
| 129 | Teratoma | 12.4% |
| 130 | Germinoma | 12.4% |
| 131 | Teratocarcinoma | 12.4% |
| 132 | Angiofibroma | 12.4% |
| 133 | Sarcoma | 12.4% |
| 134 | Epithelioma | 12.4% |
| 135 | Adenofibroma | 12.4% |
| 136 | Fibroadenoma | 12.4% |
| 137 | Malignant Fibrous Histiocytoma | 12.4% |
| 138 | Glioblastoma | 12.3% |
| 139 | Neuroblastoma | 12.3% |
| 140 | Glioblastoma Multiforme | 12.3% |
| 141 | Lymphoproliferative Disorders | 12.2% |
| 142 | Lymphatic Abnormalities | 12.2% |
| 143 | Sarcoma, Experimental | 12.2% |
| 144 | Waldenstrom Macroglobulinemia | 12.1% |
| 145 | Leukemia L1210 | 11.8% |
| 146 | Leukemia P388 | 11.8% |
| 147 | Ganglioneuroblastoma | 11.8% |
| 148 | Bowen's Disease | 11.7% |
| 149 | Paraganglioma | 11.7% |
| 150 | Rhabdomyosarcoma | 11.7% |
| 151 | Giant Cell Tumor of Bone | 11.7% |
| 152 | Bone Marrow Neoplasms | 11.6% |
| 153 | Carcinoma, Pancreatic Ductal | 11.4% |
| 154 | Pancreatic Neoplasm | 11.1% |
| 155 | Dermatofibrosarcoma | 11% |
| 156 | Dermatofibrosarcoma Protuberans | 11% |
| 157 | Neoplasms, Radiation-Induced | 10.9% |
| 158 | Acoustic Neuroma | 10.9% |
| 159 | Leukemia, T-Cell | 10.9% |
| 160 | Leukemia, B-Cell | 10.9% |
| 161 | Retroperitoneal Neoplasms | 10.7% |
| 162 | Sezary Syndrome | 10.7% |
| 163 | Sarcoma 180 | 10.5% |
| 164 | Carcinoid Heart Disease | 10.5% |
| 165 | Neurofibrosarcoma | 10.4% |
| 166 | Pheochromocytoma | 10.4% |
| 167 | Alveolar rhabdomyosarcoma | 10.4% |
| 168 | Mucocutaneous Lymph Node Syndrome | 10.1% |
| 169 | Lymphoma, Follicular | 10% |
| 170 | T-Cell Lymphoma | 10% |
| 171 | Mantle cell lymphoma | 10% |
| 172 | Plasmacytoma | 9.9% |
| 173 | Elephantiasis | 9.9% |
| 174 | Hypersplenism | 9.9% |
| 175 | Sarcoidosis | 9.9% |
| 176 | Elephantiasis Nostras Verrucosa | 9.9% |
| 177 | Vipoma | 9.7% |
| 178 | Lung Neoplasms | 9.6% |
| 179 | Pleural Neoplasms | 9.6% |
| 180 | Multiple Endocrine Neoplasia Type 1 | 9.5% |
| 181 | Optic Nerve Glioma | 9.4% |
| 182 | Hepatocellular Adenoma | 9.4% |
| 183 | Tuberous Sclerosis | 9.3% |
| 184 | Erythroplasia | 9.2% |
| 185 | Follicular cyst | 9.2% |
| 186 | Mucocele | 9.2% |
| 187 | Pilonidal Cyst | 9.2% |
| 188 | Thyroglossal Cyst | 9.2% |
| 189 | Synovial Cyst | 9.2% |
| 190 | Aberrant Crypt Foci | 9.2% |
| 191 | Leukemia, Myelomonocytic, Chronic | 9.2% |
| 192 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 9.2% |
| 193 | Esophageal Neoplasms | 9.1% |
| 194 | Basal Cell Nevus Syndrome | 9% |
| 195 | Adenocarcinoma | 9% |
| 196 | Carcinoma in Situ | 9% |
| 197 | Carcinoma, Transitional Cell | 9% |
| 198 | Phyllodes Tumor | 9% |
| 199 | Dysgerminoma | 9% |
| 200 | Hemangioendothelioma | 9% |
| 201 | Lipoma | 9% |
| 202 | Myoma | 9% |
| 203 | Myxoma | 9% |
| 204 | Neuroma | 9% |
| 205 | Papilloma | 9% |
| 206 | Pseudomyxoma Peritonei | 9% |
| 207 | Seminoma | 9% |
| 208 | Papillomatosis | 9% |
| 209 | Angiolipoma | 9% |
| 210 | Myelolipoma | 9% |
| 211 | Neoplasms, Bone Tissue | 9% |
| 212 | Neoplasms, Fibrous Tissue | 9% |
| 213 | Smooth Muscle Tumor | 9% |
| 214 | Adenomatosis, Pulmonary | 9% |
| 215 | Adenomatous Polyps | 9% |
| 216 | Carcinoma, Large Cell | 9% |
| 217 | Carcinoma, Small Cell | 9% |
| 218 | Desmoplastic Small Round Cell Tumor | 9% |
| 219 | Chondroma | 9% |
| 220 | Enchondroma | 9% |
| 221 | Agammaglobulinemia | 8.9% |
| 222 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 8.9% |
| 223 | Leukemia, Large Granular Lymphocytic | 8.9% |
| 224 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 8.9% |
| 225 | Mouth Neoplasms | 8.7% |
| 226 | Central Nervous System Neoplasms | 8.7% |
| 227 | Vascular Neoplasms | 8.7% |
| 228 | Genital Neoplasms, Female | 8.6% |
| 229 | Breast Neoplasms, Male | 8.6% |
| 230 | Triple Negative Breast Neoplasms | 8.6% |
| 231 | Lymphoma, T-Cell, Cutaneous | 8.5% |
| 232 | Lymphoma, AIDS-Related | 8.5% |
| 233 | Enteropathy-Associated T-Cell Lymphoma | 8.5% |
| 234 | Primary Effusion Lymphoma | 8.5% |
| 235 | Thyroid Nodule | 8.5% |
| 236 | Polycythemia Vera | 8.4% |
| 237 | Liver Neoplasms, Experimental | 8.3% |
| 238 | insulinoma | 8.3% |
| 239 | Heavy Chain Disease | 8.2% |
| 240 | Prolactinoma | 8.2% |
| 241 | Growth Hormone-Secreting Pituitary Adenoma | 8.2% |
| 242 | Testicular Neoplasms | 8.1% |
| 243 | Granuloma | 8.1% |
| 244 | Splenic Infarction | 8.1% |
| 245 | Histiocytosis, Langerhans-Cell | 7.9% |
| 246 | Tumor Lysis Syndrome | 7.9% |
| 247 | Gastrinoma | 7.9% |
| 248 | Glucagonoma | 7.9% |
| 249 | Denys-Drash Syndrome | 7.7% |
| 250 | Mycosis Fungoides | 7.7% |
| 251 | Lymphomatoid Papulosis | 7.7% |
| 252 | Plasmablastic lymphoma | 7.7% |
| 253 | Multiple Myeloma | 7.7% |
| 254 | Hemangioma, Cavernous | 7.7% |
| 255 | Hydatidiform Mole | 7.6% |
| 256 | Infectious Mononucleosis | 7.5% |
| 257 | Leukoplakia, Oral | 7.5% |
| 258 | Paraneoplastic Cerebellar Degeneration | 7.5% |
| 259 | Leukoplakia | 7.5% |
| 260 | Pancreatic Cyst | 7.5% |
| 261 | Leukemia, Myeloid, Chronic-Phase | 7.5% |
| 262 | Barrett Esophagus | 7.4% |
| 263 | Breast Cyst | 7.4% |
| 264 | Actinic keratosis | 7.4% |
| 265 | Mediastinal Cyst | 7.4% |
| 266 | Neoplasm Invasiveness | 7.4% |
| 267 | Neoplasm Metastasis | 7.4% |
| 268 | Neoplasm Recurrence, Local | 7.4% |
| 269 | Parovarian Cyst | 7.4% |
| 270 | Pericardial Cyst | 7.4% |
| 271 | Thymic Cyst | 7.4% |
| 272 | Carcinogenesis | 7.4% |
| 273 | Myxoid cyst | 7.4% |
| 274 | Metastasis | 7.4% |
| 275 | Lymphohistiocytosis, Hemophagocytic | 7.4% |
| 276 | Erdheim-Chester Disease | 7.4% |
| 277 | Adenoid Cystic Carcinoma | 7.3% |
| 278 | fibroma | 7.3% |
| 279 | Fibromatosis | 7.3% |
| 280 | Osteoblastoma | 7.3% |
| 281 | Osteoma | 7.3% |
| 282 | Rhabdomyoma | 7.3% |
| 283 | Chondromatosis | 7.3% |
| 284 | Adenocarcinoma, Clear Cell | 7.3% |
| 285 | Cholangiocarcinoma | 7.3% |
| 286 | Cervical Intraepithelial Neoplasia | 7.3% |
| 287 | Hemangioblastoma | 7.3% |
| 288 | Lymphoma, Extranodal NK-T-Cell | 7.3% |
| 289 | Adrenal Gland Neoplasms | 7.3% |
| 290 | Gastrointestinal Neoplasms | 7.3% |
| 291 | Genital Neoplasms, Male | 7.3% |
| 292 | Liver neoplasms | 7.3% |
| 293 | Uveal Neoplasms | 7.3% |
| 294 | Urologic Neoplasms | 7.3% |
| 295 | granulosa cell tumor | 7.2% |
| 296 | Carcinoma, Ovarian Epithelial | 7.2% |
| 297 | Bronchial Neoplasms | 7.2% |
| 298 | Sebaceous Gland Neoplasms | 7.2% |
| 299 | Spinal Neoplasms | 7.2% |
| 300 | Multiple Pulmonary Nodules | 7.1% |
| 301 | Primary amyloidosis | 7.1% |
| 302 | Leydig Cell Tumor | 7.1% |
| 303 | Adenomatous Polyposis Coli | 7% |
| 304 | Splenic Rupture | 6.8% |
| 305 | Disseminated Intravascular Coagulation | 6.6% |
| 306 | Protein S Deficiency | 6.6% |
| 307 | Limbic Encephalitis | 6.6% |
| 308 | Fibromatosis, Aggressive | 6.5% |
| 309 | Fibromatosis, Abdominal | 6.5% |
| 310 | Klatskin Tumor | 6.5% |
| 311 | Adrenocortical carcinoma | 6.5% |
| 312 | Burkitt Lymphoma | 6.4% |
| 313 | Thrombocythemia, Essential | 6.3% |
| 314 | Pleural Effusion, Malignant | 6.1% |
| 315 | Mastocytosis | 6.1% |
| 316 | Sturge-Weber Syndrome | 6.1% |
| 317 | Corpus Luteum Cyst | 6.1% |
| 318 | Ovarian Cysts | 6.1% |
| 319 | Nose Neoplasms | 6.1% |
| 320 | Gastrointestinal Stromal Tumors | 6% |
| 321 | neurofibroma | 6% |
| 322 | Lambert-Eaton Myasthenic Syndrome | 5.9% |
| 323 | Meningeal Neoplasms | 5.9% |
| 324 | Sarcoidosis, Pulmonary | 5.9% |
| 325 | Mastocytoma | 5.9% |
| 326 | Mastocytosis, Systemic | 5.9% |
| 327 | Palatal Neoplasms | 5.8% |
| 328 | Autoimmune Lymphoproliferative Syndrome | 5.8% |
| 329 | Renal Cell Carcinoma | 5.7% |
| 330 | Papillary Renal Cell Carcinoma | 5.7% |
| 331 | Pituitary Adenoma | 5.5% |
| 332 | Pituitary Neoplasms | 5.5% |
| 333 | Nasopharyngeal carcinoma | 5.5% |
| 334 | ovarian neoplasm | 5.4% |
| 335 | Carcinoma, Endometrioid | 5.4% |
| 336 | Opsoclonus-Myoclonus Syndrome | 5.3% |
| 337 | Choledochal Cyst | 5.3% |
| 338 | Peutz-Jeghers Syndrome | 5.2% |
| 339 | Thrombasthenia | 5.2% |
| 340 | Antithrombin III Deficiency | 5.2% |
| 341 | Protein C Deficiency | 5.2% |
| 342 | Ear Neoplasms | 5.1% |
| 343 | Eyelid Neoplasms | 5.1% |
| 344 | Anemia | 5% |
| 345 | Blood Coagulation Disorders | 5% |
| 346 | Blood Platelet Disorders | 5% |
| 347 | Bone Marrow Diseases | 5% |
| 348 | Hemorrhagic Disorders | 5% |
| 349 | Leukocyte Disorders | 5% |
| 350 | Methemoglobinemia | 5% |
| 351 | Pancytopenia | 5% |
| 352 | Polycythemia | 5% |
| 353 | Sulfhemoglobinemia | 5% |
| 354 | Thoracic Neoplasms | 5% |
| 355 | Thrombophilia | 5% |
| 356 | Erythrocytosis | 5% |
| 357 | Eosinophilic Granuloma | 5% |
| 358 | Brain Neoplasms | 4.9% |
| 359 | Salivary Gland Neoplasms | 4.9% |
| 360 | Spinal Cord Neoplasms | 4.9% |
| 361 | Tongue Neoplasms | 4.9% |
| 362 | Splenosis | 4.9% |
| 363 | Uterine Neoplasms | 4.9% |
| 364 | Vaginal Neoplasms | 4.9% |
| 365 | Vulvar Neoplasms | 4.9% |
| 366 | Uterine Cancer | 4.9% |
| 367 | Fallopian Tube Neoplasms | 4.9% |
| 368 | Myelitis, Transverse | 4.8% |
| 369 | Afibrinogenemia | 4.7% |
| 370 | Factor VII Deficiency | 4.7% |
| 371 | Factor X Deficiency | 4.7% |
| 372 | Factor XII Deficiency | 4.7% |
| 373 | Hemophilia A | 4.7% |
| 374 | Activated Protein C Resistance | 4.7% |
| 375 | Factor II deficiency | 4.7% |
| 376 | Factor VIII Deficiency | 4.7% |
| 377 | Factor V deficiency | 4.7% |
| 378 | Factor XI Deficiency | 4.7% |
| 379 | Hypoprothrombinemias | 4.7% |
| 380 | Pancreatic Pseudocyst | 4.6% |
| 381 | Lymphatic Metastasis | 4.6% |
| 382 | Neoplasms, Unknown Primary | 4.6% |
| 383 | Leukemic Infiltration | 4.6% |
| 384 | Thrombocytosis | 4.6% |
| 385 | Neoplasm Micrometastasis | 4.6% |
| 386 | Meningeal Carcinomatosis | 4.6% |
| 387 | Dupuytren Contracture | 4.4% |
| 388 | Vitamin K Deficiency | 4.4% |
| 389 | Pharyngeal Neoplasms | 4.4% |
| 390 | Urticaria Pigmentosa | 4.4% |
| 391 | Central Nervous System Cysts | 4.3% |
| 392 | Bile Duct Neoplasms | 4.2% |
| 393 | gallbladder neoplasm | 4.2% |
| 394 | Intestinal Neoplasms | 4.2% |
| 395 | Penile Neoplasms | 4.2% |
| 396 | Prostatic Neoplasms | 4.2% |
| 397 | Stomach Neoplasms | 4.2% |
| 398 | Transfusion Reaction | 4.2% |
| 399 | Hypotensive Transfusion Reaction | 4.2% |
| 400 | Pregnancy Complications, Hematologic | 4.1% |
| 401 | Hemoglobinuria, Paroxysmal | 3.9% |
| 402 | Leukemoid Reaction | 3.9% |
| 403 | Laryngeal neoplasm | 3.8% |
| 404 | Polycystic Ovary Syndrome | 3.8% |
| 405 | Supratentorial Neoplasms | 3.8% |
| 406 | Endometrial Neoplasms | 3.8% |
| 407 | Anemia, Diamond-Blackfan | 3.7% |
| 408 | Bladder Neoplasm | 3.7% |
| 409 | Kidney Neoplasm | 3.7% |
| 410 | Ureteral Neoplasms | 3.7% |
| 411 | Urethral Neoplasms | 3.7% |
| 412 | Purpura, Thrombotic Thrombocytopenic | 3.5% |
| 413 | Wiskott-Aldrich Syndrome | 3.5% |
| 414 | Xeroderma Pigmentosum | 3.3% |
| 415 | Anemia, Hemolytic | 3.3% |
| 416 | Anemia, Macrocytic | 3.3% |
| 417 | Eosinophilia | 3.3% |
| 418 | Hypoproteinemia | 3.3% |
| 419 | Leukopenia | 3.3% |
| 420 | Thrombocytopenia | 3.3% |
| 421 | Leukostasis | 3.3% |
| 422 | MYELODYSPLASTIC SYNDROME | 3.3% |
| 423 | Thymoma | 3.3% |
| 424 | Hypopharyngeal Neoplasms | 3.3% |
| 425 | Hypopharyngeal Cancer | 3.3% |
| 426 | Parotid Neoplasms | 3.2% |
| 427 | Prostatic Neoplasms, Castration-Resistant | 3.2% |
| 428 | Nelson Syndrome | 3.2% |
| 429 | Brain Stem Neoplasms | 3.2% |
| 430 | Anemia, Sickle Cell | 3.1% |
| 431 | Thalassemia | 3.1% |
| 432 | Choroid Plexus Papilloma | 3% |
| 433 | Autoimmune thrombocytopenia | 2.9% |
| 434 | Immune thrombocytopenic purpura | 2.9% |
| 435 | Cecal Neoplasms | 2.8% |
| 436 | Duodenal Neoplasms | 2.8% |
| 437 | Cryoglobulinemia | 2.8% |
| 438 | Monoclonal Gammopathy of Undetermined Significance | 2.8% |
| 439 | Tonsillar Neoplasms | 2.8% |
| 440 | Cerebellar Neoplasms | 2.8% |
| 441 | Cell Transformation, Viral | 2.8% |
| 442 | Anemia, Neonatal | 2.7% |
| 443 | Leukocytosis | 2.7% |
| 444 | Paraproteinemias | 2.7% |
| 445 | Pelger-Huet Anomaly | 2.7% |
| 446 | Pleocytosis | 2.7% |
| 447 | Thymus Neoplasms | 2.7% |
| 448 | Nasopharyngeal Neoplasms | 2.6% |
| 449 | Hemolytic-Uremic Syndrome | 2.5% |
| 450 | Colorectal Neoplasms | 2.5% |
| 451 | Primary Myelofibrosis | 2.5% |
| 452 | Agranulocytosis | 2.5% |
| 453 | Anemia, Megaloblastic | 2.5% |
| 454 | Lymphocytosis | 2.5% |
| 455 | Myelofibrosis | 2.5% |
| 456 | Myeloid Metaplasia | 2.5% |
| 457 | Hypoalbuminemia | 2.5% |
| 458 | Hypereosinophilic syndrome | 2.5% |
| 459 | bone marrow fibrosis | 2.5% |
| 460 | Thrombotic Microangiopathies | 2.5% |
| 461 | Purpura, Hyperglobulinemic | 2.4% |
| 462 | Sickle Cell Trait | 2.4% |
| 463 | Appendiceal Neoplasms | 2.4% |
| 464 | Colonic Neoplasms | 2.4% |
| 465 | Rectal Neoplasms | 2.4% |
| 466 | Fanconi Anemia | 2.3% |
| 467 | Paranasal Sinus Neoplasms | 2.3% |
| 468 | Zollinger-Ellison syndrome | 2.3% |
| 469 | Thrombocytopenic purpura | 2.3% |
| 470 | Hypergammaglobulinemia | 2.3% |
| 471 | Transfusion-Related Acute Lung Injury | 2.2% |
| 472 | Ecchymosis | 2.2% |
| 473 | Petechiae | 2.2% |
| 474 | Purpura | 2.2% |
| 475 | Atypical Hemolytic Uremic Syndrome | 2.2% |
| 476 | Hydrops Fetalis | 2.1% |
| 477 | Neutropenia | 2% |
| 478 | Lymphopenia | 2% |
| 479 | Job Syndrome | 2% |
| 480 | Anus Neoplasms | 2% |
| 481 | Sigmoid Neoplasms | 2% |
| 482 | Maxillary Sinus Neoplasms | 1.9% |
| 483 | Acute Chest Syndrome | 1.9% |
| 484 | Waterhouse-Friderichsen Syndrome | 1.9% |
| 485 | Febrile Neutropenia | 1.8% |
| 486 | Niemann-Pick Disease, Type C | 1.8% |
| 487 | Eosinophilia-Myalgia Syndrome | 1.7% |
| 488 | Pulmonary Eosinophilia | 1.7% |
| 489 | Eosinophilic Pneumonia | 1.7% |
| 490 | Chronic granulomatous disease | 1.6% |
| 491 | Shwartzman Phenomenon | 1.6% |
| 492 | Scurvy | 1.6% |
| 493 | Purpura Fulminans | 1.6% |
| 494 | Anemia, Pernicious | 1.6% |
| 495 | Kernicterus | 1.5% |
| 496 | Radicular Cyst | 1.4% |
| 497 | POEMS Syndrome | 1.4% |
| 498 | Pseudoxanthoma Elasticum | 1% |